Patents by Inventor Chih-Yuan MA

Chih-Yuan MA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for use in promoting wound healing
    Patent number: 10471122
    Abstract: A pharmaceutical composition for use in promoting wound healing and/or accelerating closure of an open wound in a subject in need thereof is disclosed. The composition comprises a therapeutically effective amount of a recombinant polypeptide comprising an amino acid sequence that is at least 80% identical to the amino acid sequence of SEQ ID NO: 2; and a pharmaceutically acceptable vehicle, carrier, diluent, excipients, and/or salt.
    Type: Grant
    Filed: July 26, 2016
    Date of Patent: November 12, 2019
    Assignee: Blue Blood Biotech Corp.
    Inventors: Guey-Yueh Shi, Kuan-Chieh Wang, Yi-Kai Hong, Chih-Yuan Ma, Hua-Lin Wu
  • COMPOSITION FOR USE IN PROMOTING WOUND HEALING
    Publication number: 20180200329
    Abstract: A pharmaceutical composition for use in promoting wound healing and/or accelerating closure of an open wound in a subject in need thereof is disclosed. The composition comprises a therapeutically effective amount of a recombinant polypeptide comprising an amino acid sequence that is at least 80% identical to the amino acid sequence of SEQ ID NO: 2; and a pharmaceutically acceptable vehicle, carrier, diluent, excipients, and/or salt.
    Type: Application
    Filed: July 26, 2016
    Publication date: July 19, 2018
    Inventors: Guey-Yueh SHI, Kuan-Chieh Wang, Yi-Kai HONG, Chih-Yuan MA, Hua-Lin WU
  • Methods for treatment of CD14-mediated disorders and responses
    Patent number: 9730983
    Abstract: A method for blocking, inhibiting and/or decreasing cluster of differentiation 14 (CD14) function, CD14-mediated cellular response and/or treating CD14-mediated pathological conditions is disclosed. The method comprises administering to a subject in need thereof a pharmaceutical composition comprising: (a) a therapeutically effective amount of a recombinant protein comprising an amino acid sequence that is at least 80% identical to SEQ ID NO: 1, wherein the recombinant protein does not comprises a lectin-like domain 1 of a human thrombomodulin; and (b) a pharmaceutically acceptable vehicle, carrier, diluent, excipients, and/or salt.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: August 15, 2017
    Inventors: Chih-Yuan Ma, Guey-Yueh Shi, Hua-Lin Wu
  • METHODS FOR TREATMENT OF CD14-MEDIATED DISORDERS AND RESPONSES
    Publication number: 20170095537
    Abstract: A method for blocking, inhibiting and/or decreasing cluster of differentiation 14 (CD14) function, CD14-mediated cellular response and/or treating CD14-mediated pathological conditions is disclosed. The method comprises administering to a subject in need thereof a pharmaceutical composition comprising: (a) a therapeutically effective amount of a recombinant protein comprising an amino acid sequence that is at least 80% identical to SEQ ID NO: 1, wherein the recombinant protein does not comprises a lectin-like domain 1 of a human thrombomodulin; and (b) a pharmaceutically acceptable vehicle, carrier, diluent, excipients, and/or salt.
    Type: Application
    Filed: October 2, 2015
    Publication date: April 6, 2017
    Inventors: Chih-Yuan MA, Guey-Yueh Shi, Hua-Lin Wu